Corante

About this Author
DBL%20Hendrix%20small.png College chemistry, 1983

Derek Lowe The 2002 Model

Dbl%20new%20portrait%20B%26W.png After 10 years of blogging. . .

Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: derekb.lowe@gmail.com Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Emolecules
ChemSpider
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
PubChem
Not Voodoo
DailyMed
Druglib
Clinicaltrials.gov

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
Kilomentor
A New Merck, Reviewed
Liberal Arts Chemistry
Electron Pusher
All Things Metathesis
C&E News Blogs
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
BBSRC/Douglas Kell
ChemBark
Realizations in Biostatistics
Chemjobber
Pharmalot
ChemSpider Blog
Pharmagossip
Med-Chemist
Organic Chem - Education & Industry
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
SimBioSys
The Curious Wavefunction
Natural Product Man
Fragment Literature
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Business|Bytes|Genes|Molecules
Eye on FDA
Chemical Forums
Depth-First
Symyx Blog
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa


Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
FuturePundit
Aetiology
Gene Expression (I)
Gene Expression (II)
Sciencebase
Pharyngula
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
Cosmic Variance
Biology News Net


Medical Blogs
DB's Medical Rants
Science-Based Medicine
GruntDoc
Respectful Insolence
Diabetes Mine


Economics and Business
Marginal Revolution
The Volokh Conspiracy
Knowledge Problem


Politics / Current Events
Virginia Postrel
Instapundit
Belmont Club
Mickey Kaus


Belles Lettres
Uncouth Reflections
Arts and Letters Daily
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« If It's Not One Thing. . . | Main | Name Reactions for One Thousand, Alex »

January 26, 2006

Ah, It's Fine. Just Send the Darn Thing Out Already.

Email This Entry

Posted by Derek

Since I was mentioning the other day how little I enjoy reading (or writing) patents, I thought I'd pass along this item from Greg Aharonian's PatNews mailing list. There are plenty of other people, it seems, whose attentions wander while doing IP work. Take, for example, the luckless 3 inventors from the New York area who filed application US 20030004652, which published about three weeks ago.

They've got a (putatively new) system to monitor animal behavior during drug testing. The abstract starts off by describing:

A  system  and method used to assess animal behavior includes a module having sensors that collects a variety of physical and biological data from a test subject. Interpretation of the data is provided to assess the  test subject's behavior, neurology, biochemistry and physiology. The module  is  useful in observing the effects of a drug on the test animal and providing information on the drug's signature.

OK, fine. I'm pretty sure I've seen things like this before, but who knows, maybe they have something inventive in there. So, you're asking, what are the wonderful features of this new invention? As you'll see, the folks who drafted (and edited) the abstract were asking themselves the same question during the document's preparation. Verbatim, it continues with the following, whose unsteady grammar is the least of its problems:

Another advantage is module's portability that allows it to be used in standard laboratory cages.  (NOT SURE ABOUT THIS PORTABILITY) This portability allows the animal to be tested in its own habitat, that can reduce any erroneous data due to stressing the animal when removed to a test cage.

Proofreading, guys, proofreading. You're going to have a tough time with the novelty and enablement requirements if you tell the patent office what you really think, you know.

Comments (7) + TrackBacks (0) | Category: Patents and IP


COMMENTS

1. dlib on January 26, 2006 11:10 PM writes...

almost as funny as:

US 6368227

Cheers,

Dlib

Permalink to Comment

2. Bill Tozier on January 26, 2006 11:14 PM writes...

You know, you made me go back to the NSF grant proposal I just wrote and check, again -- twice -- for comments like that.

Which is useful.

Except there weren't any such comments.

But I'm still worried....

Permalink to Comment

3. Tarzan on January 27, 2006 11:07 AM writes...

from pat # 6368227

Lastly, it should be noted that because pulling alternately on one chain and then the other resembles in some measure the movements one would use to swing from vines in a dense jungle forest, the swinging method of the present invention may be referred to by the present inventor and his sister as "Tarzan" swinging. The user may even choose to produce a Tarzan-type yell while swinging in the manner described, which more accurately replicates swinging on vines in a dense jungle forest. Actual jungle forestry is not required.

Permalink to Comment

4. Monte Davis on January 27, 2006 2:54 PM writes...

Analogous: I did a lot of hired-gun writing and consulting for new drug launches, including a part in the vetting of the (drum roll) package insert. I recall several times when work-in-progress comments like that survived several drafts before anyone else noticed. It signaled sheer fatigue on the 167th draft -- but more than that, a forest/trees perspective problem.

Honest, I understood the concerns and constraints of medical, marketing, and legal participants. But with all three of those mills grinding so fine, few nourishing grains of actual communication survived for the patient, pharmacist or even doctor.

All hail the Triumph of the Process.

Permalink to Comment

5. Andrew Dalke on January 27, 2006 4:46 PM writes...

Whenever I make a parenthetical comment like that I start with an "XXX". Easy to spot, easy to search for.

Permalink to Comment

6. SRC on January 27, 2006 10:58 PM writes...

Whenever I make a parenthetical comment like that I start with an "XXX". Easy to spot, easy to search for.

Low tech. In Word use Insert/Comments. They won't print, unless you force them to, and they're easy to find through View/Comments.

Permalink to Comment

7. Anonymous BMS Researcher on October 17, 2007 6:08 AM writes...


Since much of my work involves coding in Perl, my typical "flag" for such in prose as well as in code is to begin a line containing such with

# FIXME

because Perl is among the programming languages that use the '#' character to denote comments (which are not part of the actual code).

In comp.risks there is a long-standing tradition of stories about such stuff persisting in the final document, for instance getting a contract proposal in Microsoft Word format and discovering the other party left revision tracking enabled so the file contains details of their internal discussions, which they would probably not wish the recipients to see.

Permalink to Comment

POST A COMMENT




Remember Me?



EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
XKCD on Protein Folding
The 2014 Chemistry Nobel: Beating the Diffraction Limit
German Pharma, Or What's Left of It
Sunesis Fails with Vosaroxin
A New Way to Estimate a Compound's Chances?
Meinwald Honored
Molecular Biology Turns Into Chemistry
Speaking at Northeastern